TSHA logo

TSHATaysha Gene Therapies Inc

$5.74
$0.28
(4.69%)
Today
Closed $5.69
$0.05
(0.88%)
After Hours
Updated: 04:34 PM EDT
Reported EarningsMay 6
Mkt Cap$1.72B
Vol1.55M

About

Taysha Gene Therapies, Inc. is a clinical-stage biotechnology company, which engages in the development and commercialization of adeno-associated viruses (AAV) based gene therapies for the treatment of monogenic diseases of the central nervous system. It also develops multiple gene therapy platforms which include AAV9 Discovery, Novel Capsid, and AAV Redosing. The company was founded by Steven Gray, Berge Minassian, and R. A. Session II in 2019 and is headquartered in Dallas, TX.
Sector:
Health Technology
Industry:
Biotechnology
Employees:
99

Frequently Asked Questions

What is Market Cap of Taysha Gene Therapies Inc?
What is the 52-week high for Taysha Gene Therapies Inc?
What is the 52-week low for Taysha Gene Therapies Inc?
What is Taysha Gene Therapies Inc stock price today?
What was Taysha Gene Therapies Inc stock price yesterday?
What is the PE ratio of Taysha Gene Therapies Inc?
What is the Price-to-Book ratio of Taysha Gene Therapies Inc?
What is the 50-day moving average of Taysha Gene Therapies Inc?
How many employees does Taysha Gene Therapies Inc have?